Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

JD Sports H1 sales slip, FY pre-tax profits seen in line with expectations

(Sharecast News) - Sports fashion retailer JD Sports said on Wednesday that it expects FY26 pre-tax profits to meet current market expectations despite seeing group sales fall in the six months ended 2 August. JD Sports said H1 group sales were down 2.5% on a like-for-like basis at £5.94bn, with North American sales down 3.8% at £2.31bn, UK sales dropping by 3.3% to £1.46bn, Asia-Pacific sales slipping 2.4% to £238m and European sales contracting 0.4% to £1.92bn.

However, the FTSE 250-listed firm stated it had seen an improved sales trend across North America, Europe and the Asia-Pacific regions in the second quarter, with organic sales up 4.8%, 5.4% and 9.3%, respectively. The UK, on the other hand, saw like-for-like sales continue to decline, down 6.1% in the period, affected by tough prior year comparatives due to Euro 2024 tournament.

Including acquisitions, JD Sports stated its overall gross margin in H1 was 60 basis points lower year-on-year.

JD Sports, which announced a new £100m share buyback programme, reflecting confidence in medium-term industry growth and ongoing market share gains, said FY26 profits before tax and adjusting items were still tracking in line with market expectations, but also noted that it was continuing to assess potential impacts from US tariffs.

Chief exexutive Regis Schultz said: "Across our regions and fascias, in general we see a resilient consumer, albeit very selective on their purchases. We therefore remain cautious on the trading environment going into H2. For our FY26 profit before tax and adjusting items we expect to be in line with current market expectations, before any indirect impact of US tariffs which we continue to work through.

"We are well placed to continue growing our market share in the key growth regions of North America and Europe, and confident about the medium-term growth prospects for our industry."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.